Manmeet Ahluwalia, M.D., MBA, FASCO, is the chief scientific officer, chief of medical oncology, deputy director and Fernandez Family Endowed Chair in Cancer Research at Baptist Health Miami Cancer Institute. For over a decade, he has led practice-changing research for developing new therapies for patients with primary brain tumors and brain metastases, resulting in his 250+ peer-reviewed papers. He designed and led the initial studies on combining immunotherapy/targeted therapy and radiosurgery in brain metastases. Prior to joining Baptist Health, Dr. Ahluwalia served as the Miller Family Endowed Chair in Neuro-Oncology and the head of operations at Burkhardt Brain Tumor and Neuro-Oncology Center for Cleveland Clinic, Ohio. Dr. Ahluwalia completed internal medicine training at Cleveland Clinic Health System and fellowship training at Roswell Park Cancer Institute in 2009. Dr. Ahluwalia has received several prestigious awards, including the Fellowship of the American Society of Clinical Oncology (ASCO), the National Cancer Institute/CTEP Career Development Award via the American Brain Tumor Consortium (ABTC), ASCO Leadership Development Program, Most Distinguished Physician Award of AAPI, amongst others. Just recently, Dr. Ahluwalia was elected to join the prestigious American Society for Clinical Investigation (ASCI).
